Conference
Combination therapy with IL-2 and wild-type p53 expressed by Ad-vectors induces tumor regression in vivo without cytokine related toxicity
Authors
Putzer BM; Bramson JL; Addison CL; Muller WJ; Graham FL
Volume
4
Pagination
pp. P137-P137
Publisher
APPLETON & LANGE
Publication Date
November 1, 1997
Conference proceedings
CANCER GENE THERAPY
Issue
6
ISSN
0929-1903